Western blotting analysis confirmed that siFXR reversed TGF-β1-induced metastasis of breast cancer cells by downregulating mesenchymal markers (N-cadherin and vimentin) and upregulating the epithelial marker E-Cadherin. The gene discussed is TGFB1; the disease is breast carcinoma.